Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$13.94 USD
+0.29 (2.12%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $13.94 0.00 (0.00%) 6:28 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
SBRA 13.94 +0.29(2.12%)
Will SBRA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SBRA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SBRA
Sabra (SBRA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabra Healthcare (SBRA) Lags Q4 FFO and Revenue Estimates
SBRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ahead of Sabra (SBRA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Alexander's (ALX) Lags Q4 FFO Estimates
Is Invesco KBW Premium Yield Equity REIT ETF (KBWY) a Strong ETF Right Now?
Other News for SBRA
Sabra Health Care REIT, Inc. Announces First Quarter 2024 Earnings Release Date and Conference Call
SBRA Makes Bullish Cross Above Critical Moving Average
What's Driving Medical Properties Trust Inc's Surprising 16% Stock Rally?
Healthpeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth
Truist Financial Keeps Their Buy Rating on Sabra Healthcare REIT (SBRA)